The safety of influenza vaccine in clinically cured leprosy patients in China

References

• Britton WJ., Lockwood DN. Leprosy. Lancet. 2004;363:1209–19. doi:10.1016/S0140-6736(04)15952-7. PMID:15081655.
   PubMed Web of Science ®Google Scholar
• WHO. Global leprosy update, 2013. Reducing disease burden. Wkly Epidemiol Rec. 2014;89(36):389–400
   Google Scholar
• Quandelacy TM., Viboud C., Charu V., Lipsitch M., Goldstein E. Age- and sex-related risk factors for influenza-associated mortality in the united states between 1997–2007. Am J Epidemiol. 2014;179:156–67. doi:10.1093/aje/kwt235. PMID:24190951.
   PubMed Web of Science ®Google Scholar
• Tamura S., Tanimoto T., Kurata T. Mechanisms of broad cross-protection provided by influenza virus infection and their application to vaccines. Jpn J Infect Dis. 2005;58:195–207. PMID:16116250.
   PubMed Web of Science ®Google Scholar
• Bobosha K., Wilson L., van Meijgaarden KE., Bekele Y., Zewdie M., van der Ploeg-van Schip JJ., Abebe M., Hussein J., Khadge S., Neupane KD, et al. T-cell regulation in lepromatous leprosy. PLoS Negl Trop Dis 2014;8:e2773. doi:10.1371/journal.pntd.0002773. PMID:24722473.
   PubMed Web of Science ®Google Scholar
• Modlin RL. The innate immune response in leprosy. Curr Opin Immunol. 2010;22:48–54. doi:10.1016/j.coi.2009.12.001. PMID:20060279.
   PubMed Web of Science ®Google Scholar
• Lastória JC., Abreu MA. Leprosy: review of the epidemiological, clinical, and etiopathogenic aspects - part 1. An Bras Dermatol. 2014;89:205. doi:10.1590/abd1806-4841.20142450. PMID:24770495.
   PubMed Web of Science ®Google Scholar
• Belopasov VV., Androsiuk Iu G., Diachina MN. [Leprous neuropathies]. Zhurnal nevrologii i psikhiatrii imeni SS Korsakova. 2004;104:19–24.
   PubMedGoogle Scholar
• Lockwood DN., Saunderson PR. Nerve damage in leprosy: a continuing challenge to scientists, clinicians and service providers. Int Health. 2012;4:77–85. doi:10.1016/j.inhe.2011.09.006. PMID:24029146.
   PubMed Web of Science ®Google Scholar
• Scollard DM., Truman RW., Ebenezer GJ. Mechanisms of nerve injury in leprosy. Clin Dermatol. 2015;33:46–54. doi:10.1016/j.clindermatol.2014.07.008. PMID:25432810.
   PubMed Web of Science ®Google Scholar
• Ismail HEA. Sural artery perforator flap with posterior tibial neurovascular decompression for recurrent foot ulcer in leprosy patients. GMS Interdiscip Plast Reconstr Surg DGPW. 2017;6:Doc01. PMID:28194322.
   PubMed Web of Science ®Google Scholar
• Brandsma JW., Macdonald MR., Warren AG., Cross H., Schwarz RJ., Solomon S., Kazen R., Gravem PE., Shrinivasan H. Report from the workshop on the Neurologically Impaired foot: 5–9 June 2000, Green Pastures Hospital, Pokhara, Nepal. Assessment and examination of the neurologically impaired foot. Lepr Rev. 2001;72:254. PMID:11715271.
   PubMedGoogle Scholar
• Fukutomi Y., Matsuoka M., Minagawa F., Toratani S., McCormick G., Krahenbuhl J. IL-10 treatment of macrophages bolsters intracellular survival of Mycobacterium leprae. Int J Lepr Other Mycobact Dis. 2004;72:16–26. PMID:15217319.
   PubMedGoogle Scholar
• Mangan PR., Harrington LE., O'Quinn DB, Helms WS., Bullard DC., Elson CO., Hatton RD., Wahl SM., Schoeb TR., Weaver CT. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature. 2006;441:231. PMID:16648837.
   PubMed Web of Science ®Google Scholar
• Korn T., Bettelli E., Gao W, Awasthi A., Jäger A., Strom TB., Oukka M., Kuchroo VK. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature. 2007;448:484. PMID:17581588.
   PubMed Web of Science ®Google Scholar
• Cheng WU., Xiao Hong ZHOU., Cai Xia LI. The Expression and Significance of Th1, Th2 and Th17 Cells Related Cytokines in Peripheral Blood of Leprosy patients. Chin J Derm Venereol. 2014:998–1000.
   Google Scholar
• Minagawa F., Yoshino Y., Abe M., Saito N., Ohsawa Y., Ozawa T., Saikawa K. [Epidemiological immunological studies on leprosy in Okinawa. 6. Lepromin, lymphocyte transformation, FLA-ABS and leproagglutination tests in the in-and out-patients with leprosy and the relationships among these tests and personal or family history or clinical findings of the patients]. Nihon Rai Gakkai zasshi. 1989;58:92–111. PMID:2697714.
   PubMedGoogle Scholar
• Surls J., Nazarov-Stoica C., Kehl M., Casares S., Brumeanu TD. Differential effect of CD4+Foxp3+ T-regulatory cells on the B and T helper cell responses to influenza virus vaccination. Vaccine. 2010;28:7319–30. PMID:20832492.
   PubMed Web of Science ®Google Scholar
• Brown DM., Román E., Swain SL. CD4 T cell responses to influenza infection. Semin Immunol. 2004;16:171. PMID:15130501.
   PubMed Web of Science ®Google Scholar
• Roy-Ghanta S., Van dMR, Li P., Vaughn DW. Responses to A(H1N1)pdm09 Influenza Vaccines in Participants Previously Vaccinated With Seasonal Influenza Vaccine: A Randomized, Observer-Blind, Controlled Study. J Infect Dis. 2014;210:1419–30. doi:10.1093/infdis/jiu284. PMID:24864125.
   PubMed Web of Science ®Google Scholar
• Mesali H., Ajami A., Hussein-Nattaj H, Rafiei A., Rajabian Z., Asgarian-Omran H., Hosseini V., Taghvaei T., Tehrani M. Regulatory T Cells and Myeloid-Derived Suppressor Cells in Patients with Peptic Ulcer and Gastric Cancer. Iran J Immunol. 2016;13:167. PMID:27671508.
   PubMed Web of Science ®Google Scholar
• Hollingsworth TD., Adams ER., Anderson RM., Atkins K., Bartsch S., Basáñez MG., Behrend M., Blok DJ., Chapman LA., Coffeng L, et al. Quantitative analyses and modelling to support achievement of the 2020 goals for nine neglected tropical diseases. Parasit Vectors. 2015;8:630. doi:10.1186/s13071-015-1235-1. PMID:26652272.
   PubMed Web of Science ®Google Scholar
• Global leprosy update, 2015. time for action, accountability and inclusion. Releve Epidemiologique Hebdomadaire. 2015;91:405. PMID:27592500.
   PubMedGoogle Scholar
• Surhone LM., Timpledon MT., Marseken SF. National Institute of Allergy and Infectious Diseases. Science. 2011;50(1):22–22.
   Google Scholar
• WHO/HIS/EMP/QSS Causality Assessment of an Adverse Event Following Immunization [AEFI]; 2013. ISBN 978924150533d.
   Google Scholar